Boryung Pharmaceutical Co., Ltd. – Product Pipeline Review –

1. 2012 ||Product Pipeline|| Boryung Pharmaceutical Co., Ltd. – Product Pipeline || Aarkstore.comhttp://www.aarkstore.com/reports/Boryung-Pharmaceutical-Co-Ltd-Product-Pipeline-Review-2012-236240.html You can also request for sample page of above mention reports on sample@aarkstore.com

2. Pages : 22PDF - $ 1500 | Site Licence - $ 3000 $ | Enterprise License - $ 4500 • 20% Off on above 1000$ Reports 25% off on purchase of 2 reports and 30% on purchase of 3 or more reports. • Discount till 31st Dec. 2012.

3. SummaryGlobal Market Direct’s pharmaceuticals report, “Boryung Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012” provides data on the Boryung Pharmaceutical Co., Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Boryung Pharmaceutical Co., Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Boryung Pharmaceutical Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.

4. Scope- Boryung Pharmaceutical Co., Ltd. - Brief Boryung Pharmaceutical Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Boryung Pharmaceutical Co., Ltd. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. Reasons to buy - Evaluate Boryung Pharmaceutical Co., Ltd.’s strategic position with total access to detailed information on its product pipeline.  - Assess the growth potential of Boryung Pharmaceutical Co., Ltd. in its therapy areas of focus.  - Identify new drug targets and therapeutic classes in the Boryung Pharmaceutical Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

5. Table Of Contents List of Tables 3 List of Figures 3 Boryung Pharmaceutical Co., Ltd. Snapshot 4 Boryung Pharmaceutical Co., Ltd. Overview 4 Key Information 4 Key Facts 4 Boryung Pharmaceutical Co., Ltd. – Research and Development Overview 5 Key Therapeutic Areas 5 Boryung Pharmaceutical Co., Ltd. – Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products – Monotherapy 8 Boryung Pharmaceutical Co., Ltd. – Pipeline Products Glance 9 Boryung Pharmaceutical Co., Ltd. – Late Stage Pipeline 9 Phase III Products/Combination Treatment Modalities 9 Boryung Pharmaceutical Co., Ltd. – Early Stage Pipeline Products 10 Pre-Clinical Products/Combination Treatment Modalities 10……………..

6. Related Reports:Product Pipeline Review – 2012 http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1 Actinium Pharmaceuticals, Inc. – Product Pipeline Review – 2012VakzineProjekt Management GmbH – Product Pipeline Review – 2012Torrent Pharmaceuticals Limited – Product Pipeline Review – 2012ViroMed Co., Ltd. – Product Pipeline Review – 2012Otsuka Holdings Co., Ltd. – Product Pipeline Review – 2012Suven Life Sciences Ltd. – Product Pipeline Review – 2012TrimelBioPharma SRL – Product Pipeline Review – 2012

7. For More details about above & other Reports plz contact :Lavanya Aarkstore.com Contact: Marketing team Mob.No.918149852585  Email: enquiry@aarkstore.com URL: http://www.aarkstore.comhttp://in.linkedin.com/in/aarkstorehttp://www.facebook.com/aarkstore